Dr. Tasciotti is a Professor of Nanomedicine, Director of the Center for Biomimetic Medicine at the Department of Regenerative Medicine, and Director of the Center for Musculoskeletal Regeneration at the Houston Methodist Hospital, besides holding affiliated and honorary positions in 6 universities in USA, Europe and Asia. His research interests are in the field of biomimetic nanomaterials for drug delivery and tissue engineering. He received over $15M by DoD and DARPA to create bioactive nanomaterials to regenerate musculoskeletal tissues, and over $10M from NIH, NSF, CPRIT and private foundations to develop nanoparticles for drug delivery. He coordinates a multidisciplinary research group of 20 people, has published more than 130 research articles, filed 15 patent applications, contributed to 12 technical books and presented at over 200 international conferences.
Dr. Tasciotti's research focuses on developing innovative nanotechnology platforms and biomaterials for drug delivery and regenerative medicine which include:
-Biomimetic materials to improve tissue regeneration and modulate the immune response.
-Artificial biomimetic extracellular matrices for musculoskeletal drug delivery and regenerative medicine.
-Bio-inspired and cell-based delivery platforms for the active targeting of inflammation.
-Nanostructured hydrogels for the localized sustained release of clinically approved drugs.
-Development of new surgical procedures and clinical approaches using nano-based therapeutics.
Musculoskeletal regenerative medicine, Bioengineering, Polymer chemistry, Nanotechnology, Drug Delivery, Cancer biology.
Available equipment and techniques: